LUMICKS
LIVE

Serial Number

79307074

Owner

Lumicks DSM Holding B.V.

Filing Date

Jan 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LUMICKS Trademark

Serial Number: 79307074 • Registration: 6951814

LUMICKS is a trademark filed by Lumicks DSM Holding B.V. on January 12, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Lumicks DSM Holding B.V. (7 trademarks)

Paalbergweg 3

Entity Type: 99

LUMICKS B.V. (7 trademarks)

Pilotenstraat 41

Entity Type: 16

Trademark Details

Filing Date

January 12, 2021

Registration Date

January 17, 2023

Published for Opposition

November 1, 2022

Goods & Services

Scientific instruments, namely, cell avidity based analyzers, cell avidity based sorters and optical tweezers for studying, analyzing and manipulating biological processes at the single molecule or single cell level; scientific instruments in the nature of microscopes, cells analyzers being cell avidity based analyzers, cell sorters and computers for studying, analyzing and manipulating complex biological processes, namely, binding force on cells; calculating machines, data processing equipment, computers; downloadable and recorded computer software for scientific apparatus and instruments, namely, software used for measuring and analyzing the binding of cells to other cells and to biomolecules such as proteins, lipid membranes, sugars, antibodies and nucleic acids; downloadable and recorded computer software for scientific apparatus and instruments, namely, software used for screening, separating, enriching, selecting and sorting cells, based on the binding force on cells; downloadable and recorded computer software for microfluidic chip force spectrometer, namely, software used for controlling a force on cells; downloadable and recorded analysis software for analyzing microscopy images of cells; downloadable and recorded computer software for scientific apparatus and instruments, namely, software used for measuring, manipulating and analyzing single molecules, biomolecules, biomaterials and other molecular materials; downloadable and recorded computer software for analyzing single molecule experiments; fire-extinguishing apparatus

Pharmaceutical preparations for the treatment of infectious diseases, cancer, immune system related diseases, autoimmune disorders, diabetes, kidney diseases, respiratory infections, brain diseases, heart diseases, and cardiovascular diseases; vaccines; antibacterial pharmaceuticals; veterinary preparations for treatment of infectious diseases, cancer, immune system related diseases, autoimmune disorders, diabetes, kidney diseases, respiratory infections, brain diseases, heart diseases, and cardiovascular diseases; sanitary preparations for medical purposes; dietetic food and substances, namely, dietetic sugar and dietetic beverages, all adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; medical plasters; materials for dressings, namely, medical dressings, bandages for dressings, gauze for dressings; material for stopping teeth; dental wax; disinfectants

Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; adhesives used in industry

Medical services; veterinary services; hygienic and beauty care for human beings and animals

Medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer and other molecule-based and cell-based diagnostic testing and cytology

Scientific and technological services, namely, scientific research, biological research and analysis, single-molecule research and analysis, drug discovery services, and clinical research in the fields of immunology, oncology and other cell based diagnostic testing and cytology; design and development of computer hardware and software

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 16, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 26, 2023 FICS
FINAL DISPOSITION PROCESSED
Apr 26, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 17, 2023 FICR
CHANGE OF OWNER RECEIVED FROM IB
Feb 4, 2023 CHLD
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 17, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 17, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Nov 1, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 12, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 12, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2022 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 11, 2022 OPNX
EXAMINER'S AMENDMENT ENTERED
Aug 29, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 29, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 29, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 29, 2022 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 24, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 24, 2022 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 4, 2022 ERFR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 10, 2022 ADCH
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 22, 2022 GNFN
FINAL REFUSAL E-MAILED
Feb 22, 2022 GNFR
FINAL REFUSAL WRITTEN
Feb 22, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2022 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2021 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
Aug 20, 2021 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 2, 2021 RFCS
REFUSAL PROCESSED BY MPU
Aug 2, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 25, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jul 24, 2021 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 26, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 18, 2021 REPR